Public health impact and cost-effectiveness of 15-valent pneumococcal conjugate vaccine use among the pediatric population of the United States
Namrata Prasad, Charles Stoecker, Wei Xing, Bo‐Hyun Cho, Andrew J. Leidner, Miwako Kobayashi
Topics & Concepts
Pneumococcal conjugate vaccineMedicineVaccinationPopulationCost effectivenessPediatricsCohortPneumococcal diseaseIncidence (geometry)Quality-adjusted life yearImmunizationPublic healthEnvironmental healthPneumococcal vaccineImmunologyStreptococcus pneumoniaeInternal medicineAntigenBacteriaGeneticsOpticsRisk analysis (engineering)PhysicsNursingBiologyPneumonia and Respiratory InfectionsRespiratory viral infections researchAdvanced Causal Inference Techniques